Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression

Molecular and Cellular Neuroscience

Volumn 26, Issue 1, 2004, Pages 135-143

  Lorincz, Matthew T ^a   Detloff, Peter J ^b,c   Albin, Roger L ^a,d   O'Shea, K Sue ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NEURON RESTRICTIVE SILENCER FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; POLYGLUTAMINE; PROTEIN; REPRESSOR ELEMENT 1 TRANSITION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOUSE; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MODELS, BIOLOGICAL; NEURONS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; PLURIPOTENT STEM CELLS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 2342474624     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2004.01.016     Document Type: Article

References (56)

1. Abe Y., Kouyama K., Tomita T., Tomita Y., Ban N., Nawa M., Matsuoka M., Niikura T., Aiso S., Kita Y., Iwatsubo T., Nishimoto I. Analysis of neurons created from wild-type and Alzheimer's mutation knock-in embryonic stem cells by a highly efficient differentiation protocol. J. Neurosci. 23:2003;8513-8525
2. Ballas N., Battaglioli E., Atouf F., Andres M.E., Chenoweth J., Anderson M.E., Burger C., Moniwa M., Davie J.R., Bowers W.J., Federoff H.J., Rose D.W., Rosenfeld M.G., Brehm P., Mandel G. Regulation of neuronal traits by a novel transcriptional complex. Neuron. 31:2001;353-365
3. Bhide P.G., Day M., Sapp E., Schwartz C., Sheth A., Kim J., Young A.B., Penney J., Golden J., Aronin N., DiFiglia M. Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 16:1996;5523-5535
4. Burright E.N., Clark H.B., Servadio A., Matilla T., Feddersen R.M., Yunis W.S., Duvick L.A., Zoghbi H.Y., Orr H.T. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell. 82:1995;937-948
5. Cepeda C., Ariano M.A., Calvert C.R., Flores-Hernandez J., Chandler S.H., Leavitt B.R., Hayden M.R., Levine M.S. NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66:2001;525-539
6. Cha J.H. Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 9:2000;387-392
7. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 113:2003;643-655
8. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19:1998;148-154
9. DiFiglia M., Sapp E., Chase K., Davies S., Bates G., Vonsattel J., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993
10. Donovan P.J. High Oct-ane fuel powers the stem cell. Nat. Genet. 29:2001;246-247
11. Dragatsis I., Levine M.S., Zeitlin S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 26:2000;300-306
12. Dunah A.W., Jeong H., Griffin A., Kim Y.M., Standaert D.G., Hersch S.M., Mouradian M.M., Young A.B., Tanese N., Krainc D. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 296:2002;2238-2243
13. Duyao M.P., Auerbach A.B., Ryan A., Persichetti F., Barnes G.T., McNeil S.M., Ge P., Vonsattel J.P., Gusella J.F., Joyner A.L. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science. 269:1995;407-410
14. Gélinas S., Chapados C., Beauregard M., Gosselin I., Martinoli M.-G. Effect of oxidative stress on stability and structure of neurofilament proteins. Biochem. Cell Biol. 78:2000;667-674
15. Graveland G.A., Williams R.S., DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science. 227:1985;770-773
16. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron. 40:2003;25-40
17. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Rye D., Ferrante R.J., Hersch S.M., Li X.J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19:1999;2522-2534
18. Haung Y., Myers S.J., Dingledine R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat. Neurosci. 2:1999;867-872
19. Hooper M., Hardy K., Handyside A., Hunter S., Monk M. HPRT-deficient (Lesch-Nyan) mouse embryos derived from germline colonization by cultured cells. Nature. 326:1987;292-295
20. Koenigsberger C., Chicca J.J. II, Amoureux M.-C., Edelman G.M., Jones F.S. Differential regulation by multiple promoters of the gene encoding the neuron-restrictive silencer factor. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2291-2296
21. Li S.-H., Cheng A.L., Zhou H., Lam S., Rao M., Li H., Li X.J. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22:2002;1277-1287
22. Lin X., Antalffy B., Kang D., Orr H.T., Zoghbi H.Y. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci. 3:2000;157-163
23. Lin C., Tallaksen-Greene S., Chein W., Cearley J.A., Jackson W.S., Course A.B., Ren S., Li X.J., Albin R.L., Detloff P.J. Neurologic abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 10:2001;137-144
24. Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., Frey A.S., Spektor B.S., Penney E.B., Schilling G., Ross C.A., Borchelt D.R., Tapscott S.J., Young A.B., Cha J.-H., Olson J.M. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9:2000;1259-1271
25. McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., Fishbeck K.H. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9:2000;2197-2202
26. Mehler M.F., Gökhan S. Developmental mechanisms in the pathogenesis of neurodegenerative diseases. Prog. Neurobiol. 63:2001;336-363
27. Menalled L.B., Chesselet M.-F. Mouse models of Huntington's disease. Trends Pharmacol. Sci. 23:2002;32-39
28. Metzler M., Chen N., Helgason C.D., Grahm R.K., Kerrie N., McCutcheon K., Nasir J., Humphries R.K., Raymond L.A., Hayden M.R. Life without huntingtin: normal differentiation into functional neurons. J. Neurochem. 72:1999;1009-1018
29. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113:2003;631-642
30. Nagy A., Rossant J., Nagy R., Abramow-Newerly W., Roder J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 90:1993;8424-8428
31. Nakamura K., Jeong S.-Y., Uchihara T., Anno M., Nagashima K., Ikeda S.-I., Tsuji S., Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol. Genet. 10:2001;1441-1448
32. Nance M.A. Clinical aspects of CAG repeat diseases. Brain Pathol. 7:1997;881-900
33. Naruse Y., Tsutomu A., Kojima T., Mori N. Neural restrictive silercer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13691-13696
34. Nasir J., Floresco S.B., O'Kusky J.R., Diewert V.M., Richman J.M., Zeisler J., Borowski A., Marth J.D., Phillips A.G., Hayden M.R. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 81:1995;811-823
35. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 95:1998;379-391
36. Nucifora F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., Ross C.A. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science. 291:2001;2423-2428
37. Ordway J.M., Tallaksen-Greene S., Gutekunst C.A., Bernstein E.M., Cearley J.A., Wiener H.W., Dure L.S., Lindset R., Hersch S.M., Jope R.S., Albin R.L., Detloff R.J. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 91:1997;753-763
38. O'Shea K.S. Neuronal differentiation of embryonic stem cells. Methods Mol. Biol. vol. 198:2002;3-14 Humana Press, Totowa, NJ
39. Pesce M., Schöler H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells. 19:2001;271-278
40. Qin Z.-H., Wang Y., Sapp E., Cuiffo B., Wanker E., Hayden M.R., Kegel K.B., Aronin N., DiFiglia M. Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J. Neurosci. 24:2004;269-281
41. Robitaille Y., Lopes-Cendes I., Becher M., Rouleau G., Clark A.W. The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol. 7:1997;901-926
42. Schoenherr C.J., Paquette A., Anderson D.J. Identification of potential target genes for the neuron-restrictive silencer factor. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9881-9886
43. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 89:1997;629-639
44. Skinner P.J., Koshy B.T., Cummings C.J., Klement I.A., Helin K., Servadio A., Zoghbi H.Y., Orr H.T. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 389:1997;971-974
45. Sotrel A., Williams R.S., Kaufmann W.E., Myers R.H. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology. 43:1993;2088-2096
46. Sugars K.L., Rubinsztein D.C. Transcriptional abnormalities in Huntington disease. Trends Genet. 19:2003;233-238
47. Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., MacDonald M.E., McPhaul M.J., Brady S.T. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron. 40:2003;41-52
48. Tallaksen-Greene S.J., Ordway J.M., Crouse A.B., Jackson W.S., Detloff P.J., Albin R.L. Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J. Comp. Neurol. 465:2003;205-219
49. Tarsa L., Goda Y. Synaptophysin regulates activity-dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 99:2002;1012-1016
50. Watase K., Weeber E.J., Xu B., Antalffy B., Yuva-Paylor L., Hashimoto K., Kano M., Atkinson R., Sun Y., Armstrong D.L., Sweatt J.D., Orr H.T., Paylor R., Zoghbi H.Y. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron. 34:2002;905-919
51. Wellington C.L., Ellerby L.M., Hackam A.S., Margolis R.L., Trifiro M.A., Singaraja R., McCutcheon K., Salvesen G.S., Propp S.S., Bromm M., Rowland K.J., Zhang T., Rasper D., Roy S., Thornberry N., Pinsky L., Kakizuka A., Ross C.A., Nicholson D.W., Bredesen D.E., Hayden M.R. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273:1998;9158-9167
52. White J.K., Auerbach W., Duyao M.P., Vonsattel J.P., Gusella J.F., Joyner A.L., MacDonald M.E. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17:1997;404-410
53. Wiles M.V. Embryonic stem cell differentiation in vitro. Methods Enzymol. 225:1993;900-918
54. Yoo S.Y., Pennesi M.E., Weeber E.J., Xu B., Atkinson R., Chen S., Armstrong D.L., Wu S.M., Sweatt J.D., Zoghbi H.Y. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron. 37:2003;383-401
55. Zeitlin S., Liu J.P., Chapman D.L., Papaioannou V.E., Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11:1995;155-163
56. Zoghbi H.Y., Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23:2000;217-247